TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier(Centre international de recherche sur le cancer), Pierre Hainaut(Université Grenoble Alpes)
Cited by 2,209
Related Papers
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
|Nature|2008|1.3k
Quantitative Analysis of DNA Methylation Profiles in Lung Cancer Identifies Aberrant DNA Methylation of Specific Genes and Its Association with Gender and Cancer Risk Factors
|Cancer Research|2008|257
Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake
|Journal of Hepatology|2010|174
Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein
|Carcinogenesis|2010|67
The Evolution of Tumors in Mice and Humans with Germline p53 Mutations
|Cold Spring Harbor Symposia on Quantitative Biology|2015|19